Article

Improved cataract surgery lowers infection rates

Endophthalmitis continues to be rare after cataract surgery, according to a study by Canadian researchers.

San Francisco-Endophthalmitis continues to be rare after cataract surgery, according to a study by Canadian researchers. Surgical techniques and patient selection criteria have evolved rapidly in the past several years and researchers wanted to learn whether infection risks were changing as a result.

Records were reviewed of more than 440,000 consecutive cataract surgeries performed in surgical facilities in Ontario, Canada between April 2002 and March 2006. Facilities where more than 50 cataract surgeries were performed were included.

Postoperative procedures to treat suspected infection that occurred within 14 days of cataract surgery were tracked by the study. The overall rate of suspected acute endophthalmitis was very low: 1.4 per 1,000 surgeries.

Patients who required correction of ruptures of their lens capsule during cataract surgery were about 10 times more likely to develop suspected infection, but fewer than 1 in 200 sustained such a rupture. The highest rate of suspected endophthalmitis occurred in patients aged 85 or more years (2.18 per 1,000).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.